Aquestive Therapeutics Inc.

AQST | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.78

+$0.17 (+3.69%)

At close: Sep 21, 2026, 4:00 PM ET

$4.74

-$0.04 (-0.84%)

After-hours: Sep 21, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-83.78M	-44.14M	-7.87M	-54.41M	-70.54M	-55.78M
Depreciation & Amortization	548K	718K	1.35M	2.39M	2.96M	3.44M
Stock-Based Compensation	7.62M	7.1M	2.69M	4.38M	6.82M	6.58M
Other Working Capital	3.16M	-14.56M	-259K	24.77M	3.98M	-828K
Other Non-Cash Items	11M	10.52M	2.8M	5.85M	29.51M	4.71M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	12.18M	-9.96M	-5.34M	32.01M	-1.73M	-4.41M
Operating Cash Flow	-52.43M	-35.76M	-6.38M	-9.79M	-32.98M	-45.46M
Capital Expenditures	-562K	-159K	-995K	-2.52M	-913K	-517K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-562K	-159K	-995K	-2.52M	-913K	-517K
Debt Repayment	-37K	-23K	-20.39M	-2.03M	n/a	-22.5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-810K	-142K	15.45M	1K	329K	44.74M
Financial Cash Flow	102.62M	83.59M	3.97M	11.56M	30.11M	28.46M
Net Cash Flow	49.62M	47.67M	-3.4M	-751K	-3.78M	-17.52M
Free Cash Flow	-52.99M	-35.92M	-7.38M	-12.31M	-33.89M	-45.98M
Adj. Free Cash Flow	-60.62M	-43.02M	-10.06M	-16.69M	-40.71M	-52.56M
Maintenance CapEx	-562K	n/a	-443.69K	-2.52M	n/a	-517K
Growth CapEx	n/a	-159K	-551.31K	n/a	-913K	n/a
Owner Earnings	-52.99M	-35.76M	-6.82M	-12.31M	-32.98M	-45.98M